CBT - Cabot Corporation

NYSE - NYSE Delayed Price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/09/2022
30/09/2021
30/09/2020
30/09/2019
Total revenue
4,318,000
4,321,000
3,409,000
2,614,000
3,337,000
Cost of revenue
3,450,000
3,436,000
2,610,000
2,114,000
2,652,000
Gross profit
868,000
885,000
799,000
500,000
685,000
Operating expenses
Research development
55,000
55,000
56,000
57,000
60,000
Selling general and administrative
247,000
258,000
289,000
292,000
290,000
Total operating expenses
302,000
313,000
345,000
349,000
350,000
Operating income or loss
566,000
572,000
454,000
151,000
335,000
Interest expense
66,000
56,000
49,000
53,000
59,000
Total other income/expenses net
-2,000
-192,000
-7,000
-139,000
-30,000
Income before tax
512,000
335,000
406,000
-33,000
255,000
Income tax expense
134,000
102,000
123,000
191,000
70,000
Income from continuing operations
389,000
243,000
286,000
-221,000
186,000
Net income
352,000
209,000
250,000
-238,000
157,000
Net income available to common shareholders
348,000
209,000
250,000
-238,000
157,000
Basic EPS
-
3.65
4.35
-4.21
2.64
Diluted EPS
-
3.62
4.34
-4.21
2.63
Basic average shares
-
56,500
56,700
56,600
58,700
Diluted average shares
-
56,900
56,800
56,600
58,800
EBITDA
-
537,000
615,000
178,000
462,000